These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 10464429)
1. Cytotoxic activity of serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients against acetylcholinesterase. Niebrój-Dobosz I; Domitrz I; Mickielewicz A Folia Neuropathol; 1999; 37(2):107-12. PubMed ID: 10464429 [TBL] [Abstract][Full Text] [Related]
2. Auto-antibodies against proteins of spinal cord cells in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS). Niebroj-Dobosz I; Dziewulska D; Janik P Folia Neuropathol; 2006; 44(3):191-6. PubMed ID: 17039414 [TBL] [Abstract][Full Text] [Related]
3. Acetylcholinesterase and ATPases in motor neuron degenerative diseases. Rasool CG; Bradley WG; Connolly B; Baruah JK Muscle Nerve; 1983; 6(6):430-5. PubMed ID: 6137769 [TBL] [Abstract][Full Text] [Related]
4. Amino acids acting as transmitters in amyotrophic lateral sclerosis (ALS). Niebroj-Dobosz I; Janik P Acta Neurol Scand; 1999 Jul; 100(1):6-11. PubMed ID: 10416506 [TBL] [Abstract][Full Text] [Related]
5. Transglutaminase activity in serum and cerebrospinal fluid in sporadic amyotrophic lateral sclerosis: a possible use as an indicator of extent of the motor neuron loss. Fujita K; Honda M; Hayashi R; Ogawa K; Ando M; Yamauchi M; Nagata Y J Neurol Sci; 1998 Jun; 158(1):53-7. PubMed ID: 9667778 [TBL] [Abstract][Full Text] [Related]
6. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245 [TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283 [TBL] [Abstract][Full Text] [Related]
8. Differential diagnosis of amyotrophic lateral sclerosis from Guillain-Barré syndrome by quantitative determination of TDP-43 in cerebrospinal fluid. Hosokawa M; Arai T; Yamashita M; Tsuji H; Nonaka T; Masuda-Suzukake M; Tamaoka A; Hasegawa M; Akiyama H Int J Neurosci; 2014 May; 124(5):344-9. PubMed ID: 24066851 [TBL] [Abstract][Full Text] [Related]
9. Skeletal muscle acetylcholinesterase molecular forms in amyotrophic lateral sclerosis. Fernandez HL; Stiles JR; Donoso JA Muscle Nerve; 1986 Jun; 9(5):399-406. PubMed ID: 3724786 [TBL] [Abstract][Full Text] [Related]
10. Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems. Ruberg M; Villageois A; Bonnet AM; Pillon B; Rieger F; Agid Y J Neurol Neurosurg Psychiatry; 1987 May; 50(5):538-43. PubMed ID: 2953866 [TBL] [Abstract][Full Text] [Related]
11. [Neurotoxic activity of serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients against some enzymes of glutamate metabolism]. Niebroj-Dobosz I; Janik P; Mickielewicz A; Jamrozik Z; Kwieciński H Neurol Neurochir Pol; 2001; 35(1 Suppl):81-9. PubMed ID: 11732283 [TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid from patients with amyotrophic lateral sclerosis inhibits sonic hedgehog function. Drannik A; Martin J; Peterson R; Ma X; Jiang F; Turnbull J PLoS One; 2017; 12(2):e0171668. PubMed ID: 28170441 [TBL] [Abstract][Full Text] [Related]